Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients with Septic Shock

Update Il y a 4 ans
Reference: EUCTR2007-005441-38

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To demonstrate that treatment with drotrecogin alfa (activated) 24 mcg/kg/h administered as an intravenous infusion for 96 hours reduces 28 day all-cause mortality in adult patients with septic shock compared with placebo.


Inclusion criteria

  • Septic shock